COLUMN GROUP III LP 13D and 13G filings for Tenaya Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-07 7:50 pm Purchase |
2025-03-05 | 13D | Tenaya Therapeutics, Inc. TNYA |
COLUMN GROUP III LP | 49,313,559 32.000% |
35,714,284 (+262.62%) |
Filing |
| 2024-02-14 4:19 pm Purchase |
2024-02-12 | 13D | Tenaya Therapeutics, Inc. TNYA |
COLUMN GROUP III LP | 13,599,275 17.700% |
2,229,001 (+19.60%) |
Filing |
| 2023-02-21 5:26 pm Purchase |
2023-02-08 | 13D | Tenaya Therapeutics, Inc. TNYA |
COLUMN GROUP III LP | 11,370,274 17.800% |
1,754,890 (+18.25%) |
Filing |
| 2022-12-01 4:13 pm Purchase |
2022-11-21 | 13D | Tenaya Therapeutics, Inc. TNYA |
COLUMN GROUP III LP | 9,615,384 15.000% |
215,094 (+2.29%) |
Filing |
| 2022-02-11 4:36 pm Purchase |
2021-12-31 | 13G | Tenaya Therapeutics, Inc. TNYA |
COLUMN GROUP III LP | 9,400,290 22.800% |
9,400,290 (New Position) |
Filing |